Page 24 - GHES-3-2
P. 24

Global Health Economics and
            Sustainability
                                                                      Retrospective analysis of dialysis and kidney transplant


            care, particularly for patients in remote areas, ultimately   restoring normal kidney function and significantly
            enhancing patient QoL (Santosh et al., 2024).      improving QoL.
            5.2. Digital health tools                            The primary advantage of a kidney transplant is its
                                                               cost-effectiveness. While the upfront costs of transplant
            Mobile health apps that track dialysis schedules, medication   surgery and post-operative care can be high, long-term
            adherence, dietary intake, and symptom management can   costs are often lower than dialysis due to the reduced need
            empower patients to take control of their care, leading to   for frequent treatments and hospitalizations. In addition,
            better disease management and improved QoL (Santosh   kidney transplants significantly improve patient QoL
            et al., 2024).                                     compared to dialysis, evidenced by better health, increased
              Online support communities can provide platforms   energy levels, and greater freedom compared to the
            for  patients  to  connect  and  share  experiences,  fostering   constraints of dialysis. Transplant patients also have better
            emotional  support and  better  connection with  the   survival rates than those on dialysis, particularly with well-
            physician and ensuring patient adherence to therapy   matched living donors (Rosselli et al., 2015).
            (Santosh et al., 2024).                              However, the procedure carries surgical risks, including
            5.3. Robotics and automation                       complications related to anesthesia and rejection of
                                                               the transplanted kidney. Moreover, patients must take
            Robotic systems that automate certain aspects of dialysis   immunosuppressive drugs to prevent rejection, which
            (e.g., preparation and monitoring) can reduce human   can lead to increased vulnerability to infections and other
            error and increase the efficiency of the process, thereby   health issues. Notwithstanding, there is a significant
            enhancing patient safety and reducing operational costs   shortage of donor organs, leading to long waiting times for
            (Santosh et al., 2024).                            transplants (Rosselli et al., 2015).
              In kidney transplantation, robotic-assisted surgery can   6.2. Dialysis
            lead to less invasive procedures, shorter recovery times,
            and potentially fewer complications, improving QoL and   Dialysis is a procedure that artificially removes waste and
            reducing hospital costs (Santosh et al., 2024).    excess fluid from the blood when the kidneys can no longer
                                                               perform these functions. As discussed, there are two main
            5.4. Genomics and personalized medicine            types of dialysis (HD and PD), each with their respective
            Advances in genomics can personalize treatment strategies   advantages and disadvantages.
            based on individual genetic profiles. Personalized medicine,   Dialysis  can  be  started  quickly  without  the  need
            or precision medicine, tailors medical treatment to the   for surgery or a waiting period for an organ donor. In
            individual characteristics  of each  patient,  primarily  using   addition, patients can choose between in-center HD and
            genetic profiling and biomarker identification. This approach   home-based PD, providing some control over treatment
            allows healthcare providers to understand how genetic   schedules. Compared to kidney transplants and surgical
            variations influence disease risk and treatment responses. For   interventions, dialysis generally involves fewer immediate
            kidney transplant patients, personalized immunosuppressive   health risks (Rosselli et al., 2015).
            therapies can reduce rejection rates and side effects.
                                                                 Nonetheless, dialysis is often more expensive over time
              Santosh  et  al. (2024) discussed how genetic factors   due  to  the  need  for  regular  treatments  (usually  3  times
            contribute to the susceptibility and progression of CKD,   a week for HD) and ongoing medical care. Besides that,
            highlighting the importance of understanding the genetic   patients may experience fatigue, dietary restrictions, and
            basis of the disease. They emphasize the potential for genomics   limitations on travel and activities due to the frequency of
            to enable personalized treatment approaches, tailoring   treatments (Rosselli et al., 2015).
            interventions based on an individual’s genetic makeup. In
            addition, they explored the possibility of using genomic data   7. QoL analysis of patients
            to identify biomarkers that can improve early diagnosis and   7.1. QoL analysis of dialysis patients
            risk assessment in CKD (Gordon & Sehgal, 2000).
                                                               The QoL of dialysis patients was assessed using the Kidney
            6. Cost-effectiveness of the two therapies         Disease QoL-36 survey, which evaluates the overall health
                                                               of patients undergoing the dialysis procedure. This survey
            6.1. Kidney transplant
                                                               includes various questions about the patient’s health and
            A kidney transplant involves surgically placing a healthy   daily  life,  helping  the  physician  or  the  interviewer to
            kidney  from  a  donor  into  a  patient  with  ESRD,  thereby   identify potential challenges the patient faces with dialysis.


            Volume 3 Issue 2 (2025)                         16                       https://doi.org/10.36922/ghes.4639
   19   20   21   22   23   24   25   26   27   28   29